Corestreet Logo

Neurocrine Biosciences Inc (NBIX) Insider Trading

Total insider buys:
  • $39,032,821.44
Total insider sells:
  • $326,233,270.92
Most recent insider trade:
  • April 15, 2024
Most active insider trader:
  • Kevin Charles Gorman
Trader NameDateTitleAmountPriceTypeTotal Value
April 15, 2024Insider19,818$133.36Sell$2,642,928.48
March 21, 2024Insider5,000$145.06Sell$725,300.00
March 14, 2024Insider75,000$139.38Sell$10,453,500.00
March 14, 2024Director40,000$139.42Sell$5,576,800.00
March 11, 2024Insider200$140.00Sell$28,000.00
March 11, 2024Director100$140.00Sell$14,000.00
March 8, 2024Insider1,800$140.03Sell$252,054.00
March 8, 2024Director1,700$140.05Sell$238,085.00
Feb. 29, 2024Insider273$135.51Sell$36,994.23
Feb. 27, 2024Director8,000$135.67Sell$1,085,360.00
Feb. 20, 2024Director15,000$132.47Sell$1,987,050.00
Feb. 13, 2024Insider1,114$132.96Sell$148,117.44
Feb. 13, 2024CEO2,832$133.02Sell$376,712.64
Feb. 13, 2024CFO1,352$132.85Sell$179,613.20
Feb. 8, 2024CEO2,274$134.15Sell$305,057.10
Feb. 8, 2024Insider1,328$135.41Sell$179,824.48
Feb. 8, 2024CFO980$134.21Sell$131,525.80
Feb. 6, 2024CFO1,280$142.19Sell$182,003.20
Feb. 6, 2024Insider456$141.96Sell$64,733.76
Feb. 6, 2024CEO3,040$142.18Sell$432,227.20
Jan. 31, 2024Insider1,457$140.79Sell$205,131.03
Jan. 31, 2024CFO1,283$140.72Sell$180,543.76
Jan. 31, 2024CEO2,707$140.69Sell$380,847.83
Jan. 22, 2024Insider10,000$139.86Sell$1,398,600.00
Jan. 8, 2024CEO105,835$132.44Sell$14,016,787.40
Jan. 2, 2024Director11,044$131.47Sell$1,451,954.68
Jan. 2, 2024Insider75,000$131.47Sell$9,860,250.00
Dec. 22, 2023Insider10,000$126.74Sell$1,267,400.00
Dec. 12, 2023Insider13,925$120.30Sell$1,675,177.50
Dec. 8, 2023Insider300$120.10Sell$36,030.00
Dec. 6, 2023Insider20,830$119.86Sell$2,496,683.80
Dec. 1, 2023Director5,000$116.77Sell$583,850.00
Nov. 29, 2023Insider2,331$113.57Sell$264,731.67
Nov. 27, 2023Insider10,919$112.27Sell$1,225,876.13
Oct. 2, 2023Insider1,437$112.68Sell$161,921.16
Sept. 12, 2023Director5,000$115.02Sell$575,100.00
Sept. 1, 2023Insider824$110.93Sell$91,406.32
Sept. 1, 2023Director5,000$110.06Sell$550,300.00
Aug. 30, 2023Insider2,733$107.60Sell$294,070.80
Aug. 28, 2023Insider1,431$107.52Sell$153,861.12
Aug. 21, 2023CFO2,132$107.39Sell$228,955.48
Aug. 21, 2023CEO9,328$107.40Sell$1,001,827.20
Aug. 21, 2023Insider3,198$107.37Sell$343,369.26
May 1, 2023Director4,300$101.43Sell$436,149.00
May 1, 2023Insider11,397$103.89Sell$1,184,034.33
April 24, 2023Insider14,400$103.48Sell$1,490,112.00
April 21, 2023Director6,034$105.04Sell$633,811.36
April 19, 2023Director903$105.00Sell$94,815.00
Feb. 23, 2023Major Shareholder4,395,588$8.88Buy$39,032,821.44
Feb. 8, 2023CEO2,274$104.30Sell$237,178.20
First«1 of 6»Last

  • Insiders are both buying and selling Neurocrine Biosciences Inc stock.

  • The insider traders at Neurocrine Biosciences Inc are: Kevin Charles Gorman, Darin Lippoldt, Haig P Bozigian, Dimitri E Grigoriadis, Gary A Lyons, Christopher Flint Obrien, Eiry Roberts, Matt Abernethy, Timothy P Coughlin, Eric Benevich, Malcolm Lloyd-Smith, Kyle Gano, Richard F Pops, William H Rastetter, David W Boyer, Julie Cooke, W Thomas Mitchell, Ingrid Delaet, Stephen A Sherwin, Timothy Coughlin, Corinne H Nevinny, Jude Onyia, Haig Bozigian, Dimitri Grigoriadis, Gary A. Lyons, George J. Morrow, Leslie V. Norwalk, Haig P. Bozigian, Dimitri E. Grigoriadis, and Neurocrine Biosciences Inc

  • The most active insider trader at Neurocrine Biosciences Inc is Kevin Charles Gorman with 41 trades.

  • Kevin Charles Gorman has sold the most Neurocrine Biosciences Inc stock with a total value of $98,873,670.68.

  • Neurocrine Biosciences Inc has bought the most Neurocrine Biosciences Inc stock with a total value of $78,065,642.88.

  • The most recent insider trade for Neurocrine Biosciences Inc was on April 15, 2024.

  • The single biggest insider buy for Neurocrine Biosciences Inc was from Neurocrine Biosciences Inc with a total value of $39,032,821.44 on Feb. 23, 2023.

  • The single biggest insider sell for Neurocrine Biosciences Inc was from Kevin Charles Gorman with a total value of $33,975,315.00 on Jan. 8, 2021.